Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

BACKGROUND: COVID-19 caused by SARS-CoV-2 virus emerged as an unprecedented challenge to discover effective drugs for its prevention and cure. Hyperinflammation-induced lung damage is one of the poor prognostic indicators causing a higher rate of morbidity and mortality of COVID-19 patients. Favipir...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Rimple Jeet, Charan, Jaykaran, Dutta, Siddhartha, Sharma, Paras, Bhardwaj, Pankaj, Sharma, Praveen, Lugova, Halyna, Krishnapillai, Ambigga, Islam, Salequl, Haque, Mainul, Misra, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751706/
https://www.ncbi.nlm.nih.gov/pubmed/33364790
http://dx.doi.org/10.2147/IDR.S287934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751706/
https://www.ncbi.nlm.nih.gov/pubmed/33364790
http://dx.doi.org/10.2147/IDR.S287934

Ejemplares similares